<DOC>
	<DOCNO>NCT02057406</DOCNO>
	<brief_summary>Omega 3 supplement improve depressive symptom great extent placebo heart failure patient moderate severe major depressive disorder .</brief_summary>
	<brief_title>Omega 3 Treatment Depression Patients With Heart Failure</brief_title>
	<detailed_description>The primary objective study determine whether ( Hypothesis 1a ) ( Hypothesis 1b ) two omega 3 supplement reduce depressive symptom heart failure ( HF ) patient moderate-to-severe major depressive disorder ( MDD ) . Hypothesis 1a : Omega 3 supplement improve depressive symptom great extent placebo ; Hypothesis 1b : Pure eicosapentaenoic acid ( EPA ) superior EPA : docosahexaenoic acid ( DHA ) 2:1 depression improvement .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Adult male female patient , age great equal 21 year Diagnosis Major Depressive Disorder determine DSMIVTR criterion Hamilton Depression Rating Scale Score great equal 18* New York Heart Association Class great equal II For patient leave ventricular ejection fraction great 40 % , abnormal brain natriuretic peptide and/or previous hospitalization due heart failure also require For inpatient , Hamilton Depression Rating Scale score need remain 18 two week follow discharge Significant cognitive impairment , indicate MiniMental State Examination ( MMSE ) total score 23 low History alcohol drug dependence within past 90 day Severe physical disability ( visual , sensory , motor ) may interfere psychiatric assessment History presence psychosis , bipolar disorder , and/or severe personality disorder Lifethreatening comorbidity likelihood 50 % mortality one year Active suicidal ideation Current use antipsychotic medication psychotropic medication except SSRIs /or benzodiazepine Female patient positive pregnancy test lactating . If female patient childbearing potential , must use effective accepted mean contraception , oral contraceptive doublebarrier method ( condom diaphragm ) protect pregnancy Documented history hypersensitivity intolerance omega 3 product ; use omega 3 supplement great equal 3 month equivalent great dose propose study Treatment electroconvulsive therapy ( ECT ) transcranial magnetic stimulation ( TMS ) within 90 days* Uncorrected hypothyroidism hyperthyroidism Treatment investigational agent within 1 month randomization Acute coronary syndrome , i.e. , MI unstable angina , revascularization procedure within precede month , plan cardiac surgery within 3 month postrandomization The exclusion patient receive ECT TMS within 90 day adopt depressionintervention trial mean eliminate confounders . It believe effect ECT mood cognition may last couple month , duration TMS effect poorly know may similar ECT intervention .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>